Bigul

Biocon Biologics partner Viatris wins favourable order from US court

Biocon Biologics Ltd, said its partner Viatris has won favourable decisions from a US federal court in Sanofi's challenge over unpatentability of device patents for disposable insulin injection pen
30-12-2021

BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Biocon Biologics* Partner Viatris Wins U.S. Court Decisions on Sanofi Appeals for Lantus(r) Device Patents.
30-12-2021

BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Clinical Study for Itolizumab in Lupus Nephritis Initiated in India, Post DCGI Approval.
23-12-2021

Can booster doses prevent new variants? Here's what Kiran Mazumdar-Shaw has to say

Biocon executive chairperson Kiran Mazumdar-Shaw has sounded a warning over booster shots being administered against COVID-19 in a recent tweet
20-12-2021